- Home
- FROG vs BHC Comparison
FROG vs BHC Comparison
Compare FROG & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FROG
- BHC
- Stock Information
- Founded
- FROG 2008
- BHC N/A
- Country
- FROG United States
- BHC Canada
- Employees
- FROG N/A
- BHC N/A
- Industry
- FROG Computer Software: Prepackaged Software
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- FROG Technology
- BHC Health Care
- Exchange
- FROG Nasdaq
- BHC Nasdaq
- Market Cap
- FROG 3.6B
- BHC 3.0B
- IPO Year
- FROG 2020
- BHC N/A
- Fundamental
- Price
- FROG $31.51
- BHC $8.78
- Analyst Decision
- FROG Strong Buy
- BHC Hold
- Analyst Count
- FROG 18
- BHC 4
- Target Price
- FROG $36.29
- BHC $7.25
- AVG Volume (30 Days)
- FROG 930.6K
- BHC 2.0M
- Earning Date
- FROG 11-07-2024
- BHC 10-30-2024
- Dividend Yield
- FROG N/A
- BHC N/A
- EPS Growth
- FROG N/A
- BHC N/A
- EPS
- FROG N/A
- BHC N/A
- Revenue
- FROG $409,670,000.00
- BHC $9,474,000,000.00
- Revenue This Year
- FROG $23.68
- BHC $9.59
- Revenue Next Year
- FROG $17.92
- BHC $3.53
- P/E Ratio
- FROG N/A
- BHC N/A
- Revenue Growth
- FROG 24.45
- BHC 10.91
- 52 Week Low
- FROG $22.91
- BHC $3.96
- 52 Week High
- FROG $48.81
- BHC $11.46
- Technical
- Relative Strength Index (RSI)
- FROG 56.99
- BHC 52.02
- Support Level
- FROG $30.05
- BHC $9.19
- Resistance Level
- FROG $33.14
- BHC $9.49
- Average True Range (ATR)
- FROG 1.12
- BHC 0.37
- MACD
- FROG 0.07
- BHC -0.03
- Stochastic Oscillator
- FROG 57.63
- BHC 42.47
About FROG JFrog Ltd.
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.